Synthetic staurosporines via a ring closing metathesis strategy as potent JAK3 inhibitors and modulators of allergic responses

被引:19
作者
Wilson, Lawrence J. [1 ]
Malaviya, Ravi [3 ]
Yang, Cangming [1 ]
Argentieri, Rochelle [3 ]
Wang, Bingbing [1 ]
Chen, Xin [2 ]
Murray, William V. [1 ]
Cavender, Druie [3 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, High Throughput Chem Dept, Raritan, NJ 08869 USA
[2] Johnson & Johnson Pharmaceut Res & Dev LLC, Comp Aided Drug Design Dept, Raritan, NJ 08869 USA
[3] Johnson & Johnson Pharmaceut Res & Dev LLC, Inflammat Therapeut Dept, Raritan, NJ 08869 USA
关键词
Staurosporine; Protein kinases; Natural products; Ring closing metathesis; Immune system; CRYSTAL-STRUCTURE; NATURAL-PRODUCTS; KINASE DOMAIN; ASTHMA; CELLS;
D O I
10.1016/j.bmcl.2009.04.039
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
The synthesis and biological evaluation of JAK3 based staurosporine compounds is described. The compounds are constructed completely de novo, and a ring closing metathesis strategy is used to assemble the sugar mimetic portion. These analogs show potent JAK3 activity against isolated enzyme and in T-cells. One analog (32) showed unique biological effects during in vitro and in vivo tests including inhibition of STAT5 phosphorylation, blockade of mast cell responses, and reduction of JAK3 based effects in mice models of allergic disease. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3333 / 3338
页数:6
相关论文
共 26 条
[1]
Comparison of the ATP binding sites of protein kinases using conformationally diverse bisindolylmaleimides [J].
Bartlett, S ;
Beddard, GS ;
Jackson, RM ;
Kayser, V ;
Kilner, C ;
Leach, A ;
Nelson, A ;
Oledzki, PR ;
Parker, P ;
Reid, GD ;
Warriner, SL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (33) :11699-11708
[2]
Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog [J].
Boggon, TJ ;
Li, YQ ;
Manley, PW ;
Eck, MJ .
BLOOD, 2005, 106 (03) :996-1002
[3]
Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants [J].
Buckley, RH ;
Schiff, RI ;
Schiff, SE ;
Markert, ML ;
Williams, LW ;
Harville, TO ;
Roberts, JL ;
Puck, JM .
JOURNAL OF PEDIATRICS, 1997, 130 (03) :378-387
[4]
Casale TB, 2004, DRUG TODAY, V40, P367
[5]
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor [J].
Changelian, PS ;
Flanagan, ME ;
Ball, DJ ;
Kent, CR ;
Magnuson, KS ;
Martin, WH ;
Rizzuti, BJ ;
Sawyer, PS ;
Perry, BD ;
Brissette, WH ;
McCurdy, SP ;
Kudlacz, EM ;
Conklyn, MJ ;
Elliott, EA ;
Koslov, ER ;
Fisher, MB ;
Strelevitz, TJ ;
Yoon, K ;
Whipple, DA ;
Sun, JM ;
Munchhof, MJ ;
Doty, JL ;
Casavant, JM ;
Blumenkopf, TA ;
Hines, M ;
Brown, MF ;
Lillie, BM ;
Subramanyam, C ;
Shang-Poa, C ;
Milici, AJ ;
Beckius, GE ;
Moyer, JD ;
Su, CY ;
Woodworth, TG ;
Gaweco, AS ;
Beals, CR ;
Littman, BH ;
Fisher, DA ;
Smith, JF ;
Zagouras, P ;
Magna, HA ;
Saltarelli, MJ ;
Johnson, KS ;
Nelms, LF ;
Des Etages, SG ;
Hayes, LS ;
Kawabata, TT ;
Finco-Kent, D ;
Baker, DL ;
Larson, M .
SCIENCE, 2003, 302 (5646) :875-878
[6]
Synthesis of oxygen- and nitrogen-containing heterocycles by ring-closing metathesis [J].
Deiters, A ;
Martin, SF .
CHEMICAL REVIEWS, 2004, 104 (05) :2199-2238
[7]
Fabbro D, 2000, ANTI-CANCER DRUG DES, V15, P17
[8]
Review of UCN-01 development: A lesson in the importance of clinical pharmacology [J].
Fuse, E ;
Kuwabara, T ;
Sparreboom, A ;
Sausville, EA ;
Figg, WD .
JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (04) :394-403
[9]
Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells [J].
Hanissian, SH ;
Geha, RS .
IMMUNITY, 1997, 6 (04) :379-387
[10]
Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders [J].
Hexner, Elizabeth O. ;
Serdikoff, Cynthia ;
Jan, Mahfuza ;
Swider, Cezary R. ;
Robinson, Candy ;
Yang, Shi ;
Angeles, Thelma ;
Emerson, Stephen G. ;
Carroll, Martin ;
Ruggeri, Bruce ;
Dobrzanski, Pawel .
BLOOD, 2008, 111 (12) :5663-5671